Successful treatment of severe unconjugated hyperbilirubinemia via induction of UGT1A1 by rifampicin-Reference-Cited by-同舟云学术

Successful treatment of severe unconjugated hyperbilirubinemia via induction of UGT1A1 by rifampicin

Published:2006-01 Issue:1 Volume:44 Page:243-245
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Ellis Ewa,Wagner Martin,Lammert Frank,Nemeth Antal,Gumhold Judith,Strassburg Christian P.,Kylander Christian,Katsika Despina,Trauner Michael,Einarsson Curt,Marschall Hanns-Ulrich

Publisher

Elsevier BV

Subject

Hepatology

Reference15 articles.

1. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome;Bosma;N Engl J Med,1995

2. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype;Kadakol;Hum Mutat,2000

3. Cultured human hepatocytes form glycosidic bile acid conjugates in contrast to hepatoblastoma HepG2 cells;Ellis;Biochim Biophys Acta,2001

4. Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in human liver;Marschall;Gastroenterology,2005

5. Stimulation of bile acid 6α-hydroxylation by rifampin;Wietholtz;J Hepatol,1996

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance;Pharmacology & Therapeutics;2023-08

2. Management of Drug-Drug Interactions Between Long-Acting Cabotegravir and Rilpivirine and Comedications With Inducing Properties: A Modeling Study;Clinical Infectious Diseases;2022-11-15

3. Primary myelofibrosis with thrombophilia as first symptom combined with thalassemia and Gilbert syndrome: A case report;World Journal of Clinical Cases;2022-05-06

4. Efficacy and safety of rifampicin in patients with persistent hepatocellular secretory failure;Journal of Gastroenterology and Hepatology;2021-08-08

5. CYP3A4-mediated effects of rifampicin on the pharmacokinetics of vilaprisan and its UGT1A1-mediated effects on bilirubin glucuronidation in humans;British Journal of Clinical Pharmacology;2018-10-11